glp-1 approved for sleep apnea Medications Show Promise as First Drug Therapy GLP-1 vs. CPAP: What Works

Amongst people with HF, up to 50% are estimated to have type 2 diabetes and, vice versa, around 20% of the over 500 million people living with type 2 diabetes have been shown to have comorbid HF (Khan et al., 2020)

The second approach ultimately produced EP45, a 45 residue monomeric peptide that is a true chimera of exendin-4 and PYY336

Due to newfound popularity of GLP-1 agonists as a quick weight-loss solution, some have found their medications in short supply or more expensive, and in some cases, both

The Amylin Corporation's response to this putative link has been to suggest that it was a consequence of guilt by association rather than a drug effect since pancreatitis is more common in individuals with obesity and type 2 diabetes (15)

Biochem Soc Trans (2014) 42(2):5939